Angiotensin converting enzyme inhibitor therapy in children with Alport syndrome: effect on urinary albumin, TGF-β, and nitrite excretion
-
* Corresponding author: Howard Trachtman trachtma@lij.edu
BMC Nephrology 2002, 3:2 doi:10.1186/1471-2369-3-2
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 07 Dec 2001 | |
| Reviewer's Report | Markus Ketteler | 29 Dec 2001 | |
| Reviewer's Report | Giuliana Lama | 08 Jan 2002 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 17 Jan 2002 |
| Reviewer's Report | Markus Ketteler | 01 Feb 2002 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 12 Feb 2002 |
| Published | 14 Feb 2002 |